Salute e Benessere

Formycon and MS Pharma sign exclusive commercialization partnership for…

"This licensing deal for the MENA region represents the start of the commercial partnering activities for our Keytruda ®biosimilar candidate. Further agreements for additional regions and countries shall follow in due time. With MS Pharma, we are leveraging the well-established excellent collaboration that has already been successfully implemented for our biosimilars FYB201, FYB202, and FYB203. MS Pharma is a strong player that can sustainably improve access to this important cancer...
PR Newswire
04/12/2025

Cumulus Neuroscience Presents Data at CTAD 2025 Annual Meeting

Cumulus presented a poster titled, "Validating a Multi-Domain Digital Endpoint Platform (NeuLogiq) for Decentralized Alzheimer's Trials: Results from the CNS-101 Study," which confirms the superior sensitivity and statistical power of its proprietary NeuLogiq Platform compared to current industry benchmarks. Cumulus presented a poster titled, "Validating a Multi-Domain Digital Endpoint Platform (NeuLogiq) for Decentralized Alzheimer's Trials: Results from the CNS-101 Study,"…
PR Newswire
04/12/2025

'CART BP' Demonstrates Successful Blood Pressure Monitoring in Microgravity

The experiment was conducted by a research team from the University of Cambridge (UK) in collaboration with the International Institute of Astronautical Sciences (IIAS). The experiment was conducted by a research team from theUniversity of Cambridge(UK) in collaboration with the International Institute of Astronautical Sciences (IIAS). The IIAS-02 mission took place in a microgravity environment generated during parabolic flight, where apparent gravity approaches zero following a steep...
PR Newswire
04/12/2025

iOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new…

The Phase I/II trial is part of a comprehensive development program evaluating next-generation PI3Kδ inhibitor roginolisib's tolerability and anti-tumor response across a number of solid and hematologic malignancies. The Phase I/II trial is part of a comprehensive development program evaluating next-generation PI3Kδ inhibitor roginolisib's tolerability and anti-tumor response across a number of solid and hematologic malignancies. "Based on non-clinical data being presented at ASH, we...
PR Newswire
04/12/2025

Swedish health care region expands with Sectra and digitizes pathology for…

Region Halland has used Sectra's solutions within its radiology and breast imaging workflows for several years. Following this new addition, they will begin using Sectra's digital pathology module to further enhance their pathology workflows. Digital pathology brings numerous advantages for hospitals, pathologists, and patients alike. With Sectra's solution, Region Halland will gain a vendor-neutral and scalable system that strengthens data security and reduces time spent on manual processes…
PR Newswire
04/12/2025

The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results…

The data published in NEJM highlights the positive Phase 3 VALIANT results at Week 26, which were consistent across patients with C3G and primary IC-MPGN, adolescents and adults, and native and post-transplant kidney disease. The data published in NEJM highlights the positive Phase 3 VALIANT results at Week 26, which were consistent across patients with C3G and primary IC-MPGN, adolescents and adults, and native and post-transplant kidney disease. Pegcetacoplan showed favourable safety and...
PR Newswire
04/12/2025

New Leqembi-data presented at CTAD 2025 suggests potential to delay disease…

Real-world data from different clinics and countries were also presented at the congress, demonstrating continued clinical benefit with lecanemab treatment and a safety profile consistent with the phase 3 Clarity AD study. Real-world data from different clinics and countries were also presented at the congress, demonstrating continued clinical benefit with lecanemab treatment and a safety profile consistent with the phase 3 Clarity AD study. The presentations in summary: Estimating the...
PR Newswire
04/12/2025

With Child Deaths Projected to Rise for the First Time This Century, Gates…

In 2024, 4.6 million children died before their 5th birthday. According to modeling in the report, conducted by the Institute for Health Metrics and Evaluation (IHME), that number is projected to rise by just over 200,000—to an estimated 4.8 million children this year. At the same time, global development assistance for health fell sharply this year—26.9% below 2024 levels. Beyond this year's drastic funding cuts, countries face mounting debt, fragile health systems, and the risk of losing…
PR Newswire
04/12/2025

AI-Driven Personalized Nutrition and Wellness Solutions Market worth USD…

Growing concerns about lifestyle-related diseases, rising healthcare costs, and demand for preventive health solutions further strengthen market adoption. As individuals seek personalized guidance at scale and as enterprises embrace data-driven wellness programs the AI-driven nutrition and wellness ecosystem has become a strategic priority for public and private stakeholders. Growing concerns about lifestyle-related diseases, rising healthcare costs, and demand for preventive health solutions...
PR Newswire
04/12/2025

Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast…

Hemophilia A Market Summary Hemophilia A Market Summary Discover the new hemophilia A treatment @Hemophilia A Treatment Market Key Factors Driving the Growth of the Hemophilia A Market Rising Hemophilia A Target Patient Pool The diagnosed prevalence of Hemophilia A is expected to rise from 49K in 2024 to 50K by 2034. Improved diagnostic capabilities and increased disease awareness mainly drive this increase in cases. Advancements in Gene Therapy Gene...
PR Newswire
03/12/2025

HIV Therapeutics Market to Reach USD 57.56 Billion by 2033 as Long-Acting…

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=hiv-therapeutics-market Buy This Report with Year-End Offer( Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer):https://www.datamintelligence.com/buy-now-page?report=hiv-therapeutics-market Long-Acting ART, Ultra-Potent INSTIs & Pipeline Innovation Driving a New Era in HIV...
PR Newswire
03/12/2025

Dyspnea Treatment Market to Reach $7,346.25 Million by 2027 in the short run and…

Request Sample of the Report on Dyspnea treatment Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A273997 Request Sample of the Report on Dyspnea treatment Market Forecast 2034 –https://www.alliedmarketresearch.com/request-sample/A273997 Market Introduction The dyspnea treatment market encompasses a broad range of therapeutic solutions designed to manage and relieve shortness of breath associated with respiratory and cardiovascular conditions...
PR Newswire
03/12/2025

Wingderm® Announces MDR Certification for Renuva 1550nm Non-Ablative Fractional…

Renuva utilizes fractional photothermolysis technology, delivering controlled energy into micro-areas of the skin while preserving surrounding tissue. This approach aims to enhance the skin's appearance, supporting a comfortable and minimally interruptive beauty experience. Renuva is designed for professional settings and to allow clients to resume their daily activities with minimal interruption. Moreover, Renuva procedures can be adjusted according to professional guidance for safe operation…
PR Newswire
03/12/2025

Preclinical Imaging Market worth $4.39 billion by 2030 | MarketsandMarkets™

Preclinical Imaging Market Size & Forecast: Preclinical Imaging Market Size & Forecast: Preclinical Imaging Market Trends & Insights: Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 In vivo preclinical imaging involves the visualization of animal models required during life science research studies. This is particularly important to academic researchers and those involved in drug development activities, prior to human trials...
PR Newswire
03/12/2025

FMI Reports Strong 11.7% CAGR Growth Outlook for the GLP-1 Receptor Agonist…

Manufacturers Accelerate Innovation as Demand for Metabolic Therapies Intensifies Manufacturers Accelerate Innovation as Demand for Metabolic Therapies Intensifies Pharmaceutical manufacturers are rapidly advancingself-administration devices,parenteral innovations, andcombination therapiesto elevate patient adherence and treatment outcomes. The industry is experiencing: "GLP-1 receptor agonists have evolved from single-indication diabetes drugs to multi-benefit metabolic...
PR Newswire
03/12/2025

Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology…

Luke brings more than 25 years of international experience in oncology drug development, clinical operations, and strategic partnership management across the biotech and CRO sectors. He has led global oncology programs from first-in-human and translational research through pivotal Phase III trials and regulatory submissions, driving operational excellence and scientific rigor throughout the process. Luke brings more than 25 years of international experience in oncology drug development,...
PR Newswire
03/12/2025

Plant Extracts Market worth $85.28 billion by 2030 - Exclusive Report by…

Plant Extracts Market Size & Forecast Plant Extracts Market Size & Forecast Plant Extracts Market Trends & Insights: Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=942 Demand for plant extracts is expected to rise strongly in the coming years as consumers increasingly shift toward natural, clean-label, and botanical ingredients for health, wellness, and safe nutrition. With growing awareness of the limitations and side effects...
PR Newswire
03/12/2025

World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking…

SHIYA 20 is among the first fully integrated 3D digital microsurgery platforms, unifying visualization, ergonomics, and data capture into one surgeon-centered system. Over the past year, Prof. Hong's intensive hands-on experience with SHIYA 20 in live surgeries and global training programs has provided meaningful real-world validation for surgeons and hospitals considering next-generation digital visualization technologies. SHIYA 20 is among the first fully integrated 3D digital microsurgery...
PR Newswire
03/12/2025

S3 Connected Health Receives Frost & Sullivan's 2025 Global Company of the Year…

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. S3 Connected Health excelled in both, demonstrating exceptional alignment between market demand and strategic initiatives, delivered with scale, quality, and operational consistency. "S3 Connected Health focuses on implementing best practices for consistency and quality of delivery that resonate with its clients," said Bhaskar…
PR Newswire
03/12/2025

Daewoong Pharmaceutical Holds Nabota Master Class in Saudi Arabia

To date, Nabota has expanded into 10 countries in the Middle East—more markets than any other Korean toxin brand—achieving rapid growth in key markets such as Saudi Arabia and the UAE. In Saudi Arabia, the largest aesthetic market in the region, Nabota has continued to gain market share since its launch, solidifying its presence through consistent clinical performance. To date, Nabota has expanded into 10 countries in the Middle East—more markets than any other Korean toxin brand—achieving...
PR Newswire
03/12/2025

Brainomix Announces New Study Published in Lancet Digital Health Demonstrating…

"As a Company that prides itself on a foundation of evidence-based medicine, we are delighted with the publication of this landmark study of Brainomix 360 Stroke in Lancet Digital Health. The significant increase in mechanical thrombectomy and intravenous thrombolysis with an associated improvement in clinical outcomes validates what we have seen in other studies, but at an unprecedented scale," said Dr George Harston, Chief Medical and Innovation Officer, Brainomix, and Consultant…
PR Newswire
03/12/2025

Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast…

Narcolepsy Market Summary Narcolepsy Market Summary Discover the new narcolepsy treatment @Narcolepsy Treatment Market Key Factors Driving the Growth of the Narcolepsy Market Rising Diagnosed Narcolepsy Prevalence In 2024, DelveInsight estimated around360,000diagnosed prevalent cases of narcolepsy across the 7MM, underscoring its significant clinical burden and growing recognition as a distinct neurological disorder. These number are further expected to grow by...
PR Newswire
02/12/2025

THE U.S. POINTER STRUCTURED HEALTHY LIFESTYLE PROGRAM -- PREVIOUSLY SHOWN TO…

SAN DIEGO, Dec. 2, 2025 /PRNewswire/ -- A two-year multicomponent healthy lifestyle intervention with regular, structured support — which has already shown that it can improve cognition in adults at risk for cognitive decline — may also improve blood pressure regulation and reduce hourly sleep apnea respiratory events, according to new data reported today at CTAD 2025 in San Diego. The intervention may also protect against the negative cognitive effects of certain Alzheimer's disease-related…
PR Newswire
02/12/2025

Festive Freak-Out: Over Half of Brits Say Christmas Is More Stress Than Sparkle

When asked what - or who - causes the most festive stress, 13% of Brits say their children, 9% their partners, and another 9% confess they're their own biggest source of stress. Meanwhile, gift wrapping tops the list of Christmas traditions that secretly drive people mad (19%), followed by the post-Christmas clean up (19%) and gift buying (17%). When asked what - or who - causes the most festive stress, 13% of Brits say their children, 9% their partners, and another 9% confess they're their…
PR Newswire
02/12/2025
Altri  Comunicati